Lineage Cell Therapeutics, Inc.
LCTX- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000876343
No open-market purchases or sales by Lineage Cell Therapeutics, Inc. insiders were filed in the last 90 days; 131 institutions reported holding it in 13F filings for Q2 2026, worth $152.7M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Lineage Cell Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 115
- +13 vs. Q1 2021
- Shares held
- 73.1M
- +12.8M (+21.3%) vs. Q1 2021
- Total value
- $208.5M
- +$66.7M (+47.1%) vs. Q1 2021
- New holders
- 33
- 34 more added
- Sold out
- 20
- 15 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 131 | $152.7M |
| Q1 2026 | 130 | $176.5M |
| Q4 2025 | 123 | $169.8M |
| Q3 2025 | 112 | $148.6M |
| Q2 2025 | 129 | $88.4M |
| Q1 2025 | 127 | $49.7M |
| Q4 2024 | 126 | $53.8M |
| Q3 2024 | 114 | $85.6M |
| Q2 2024 | 113 | $94.2M |
| Q1 2024 | 116 | $138.3M |
| Q4 2023 | 115 | $82.5M |
| Q3 2023 | 104 | $89.1M |
| Q2 2023 | 107 | $106.6M |
| Q1 2023 | 116 | $104.7M |
| Q4 2022 | 106 | $76.2M |
| Q3 2022 | 104 | $73.1M |
| Q2 2022 | 100 | $102.7M |
| Q1 2022 | 109 | $112.3M |
| Q4 2021 | 124 | $182.0M |
| Q3 2021 | 115 | $191.7M |
| Q2 2021 | 115 | $208.5M |
| Q1 2021 | 102 | $141.8M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Lineage Cell Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of Montreal | 379,081 | $1.11M | 0.00% | +102,093+36.9% | Added |
| Nuveen Asset Management, LLC | 449,911 | $1.28M | 0.00% | +449,911 | New |
| DekaBank Deutsche Girozentrale | 550,000 | $1.59M | 0.00% | +550,000 | New |
| Bridgeway Capital Management, LLC | 596,427 | $1.70M | 0.03% | −46,712−7.3% | Reduced |
| Two Sigma Investments, LP | 1,314,567 | $3.75M | 0.01% | +60,036+4.8% | Added |
| Northern Trust Corp | 1,628,749 | $4.64M | 0.00% | +1,332,456+449.7% | Added |
| Two Sigma Advisers, LP | 1,824,566 | $5.20M | 0.01% | +190,700+11.7% | Added |
| Prescott General Partners LLC | 1,851,851 | $5.28M | 0.17% | 00.0% | Unchanged |
| State Street Corp | 1,868,046 | $5.32M | 0.00% | +1,802,392+2,745.3% | Added |
| JPMorgan Chase & Co | 1,952,108 | $5.56M | 0.00% | +1,952,035+2,674,020.5% | Added |
| Geode Capital Management, LLC | 2,338,584 | $6.66M | 0.00% | +1,072,633+84.7% | Added |
| Defender Capital, LLC. | 5,036,720 | $14.4M | 4.77% | +86,000+1.7% | Added |
| Vanguard Group Inc | 6,398,815 | $18.2M | 0.00% | +838,759+15.1% | Added |
| BlackRock Inc. | 8,539,530 | $24.3M | 0.00% | +6,076,041+246.6% | Added |
| Broadwood Capital Inc | 34,005,379 | $96.9M | 4.33% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −1,425,776−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −334,197−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −289,018−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −191,483−100.0% | Sold out |
| Williams Jones Wealth Management, LLC. | 0 | $0 | 0.00% | −101,300−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −80,000−100.0% | Sold out |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −75,400−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −72,194−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −48,400−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −36,162−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −33,574−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −26,712−100.0% | Sold out |
| Jefferies Group LLC | 0 | $0 | 0.00% | −24,400−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −21,090−100.0% | Sold out |
| Sciencast Management LP | 0 | $0 | 0.00% | −18,076−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −17,529−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −13,185−100.0% | Sold out |
| Gluskin Sheff & Assoc Inc | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Integrated Wealth Concepts LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Eudaimonia Partners, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |